Fundraising FoxDouble Blind Bio
San Francisco, US · Founded 2025 · Delaware corporation · 4 known investors
Find your way into Double Blind Bio
Sign up to see every warm intro you have to Double Blind Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Double Blind Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Double Blind Bio builds AI agents that automate administrative workflows within clinical trial sites and sponsor operations, enabling faster and more efficient execution of clinical studies. The company targets research sites and trial sponsors who seek to reduce repetitive work and accelerate patient access to new treatments.
Founders & leadership
Investors · 4
How we know: the company's own site · Peterson Ventures's portfolio page · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$5.6M disclosed across 1 round · 2025
▶$5.6MraisedDec 2025 · 6 investors · Other TechnologyRule 506(b)
- David HughesExecutive Officer, Director
- Shruti TibrewalaExecutive Officer, Director
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Double Blind Bio do?
- Double Blind Bio builds AI agents that automate administrative workflows within clinical trial sites and sponsor operations, enabling faster and more efficient execution of clinical studies. The company targets research sites and trial sponsors who seek to reduce repetitive work and accelerate patient access to new treatments.
- Who are Double Blind Bio's investors?
- Double Blind Bio's investors include Peterson Ventures, Define Ventures, SignalFire, StartX.
- How much funding has Double Blind Bio raised?
- Double Blind Bio has disclosed $5.6M raised across 1 round.
- Where is Double Blind Bio headquartered?
- Double Blind Bio is headquartered in San Francisco, US.